Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
CPI-0209 is a second-generation EZH2 inhibitor, which inhibits methylation of H3K27 to decrease tumor cell proliferation (NCI Drug Dictionary).
|DrugClasses||EZH2 inhibitor 18|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|CPI-0209 + Irinotecan||CPI-0209 Irinotecan||0||1|